BFM
TENX icon

Boothbay Fund Management’s Tenax Therapeutics TENX Stock Holding History

Boothbay Fund Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$529K Buy
+33,100
New +$448K 0.01% 1312

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Boothbay Fund Management's TENX Position: Q1 2026 in Review

Boothbay Fund Management increased its Tenax Therapeutics (TENX) stake by 4.1% in Q1 2026, buying an estimated $197K and bringing the position to 366,791 shares worth $5.86M. The position accounts for 0.08% of the portfolio, ranked #273.

Boothbay Fund Management first reported a position in TENX in Q3 2021 and has held it in 6 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • Boothbay Fund Management held 366,791 shares of Tenax Therapeutics worth $5.86M as of Q1 2026.
  • Boothbay Fund Management bought 14,585 Tenax Therapeutics shares in Q1 2026, an estimated $197K.
  • Tenax Therapeutics made up 0.08% of Boothbay Fund Management's portfolio in Q1 2026, its #273 holding.
  • Boothbay Fund Management first reported a position in Tenax Therapeutics in Q3 2021 and has held it in 6 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.